A clinical study of gene expression models for predicting response to S-1 in patients with head and neck squamous cell carcinoma
Phase 2
- Conditions
- Patients who are suitable for S-1 chemotherapy as a first-line treatment in head and neck squamous cell carcinoma.
- Registration Number
- JPRN-UMIN000007767
- Lead Sponsor
- Koshin Chemical Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ 2. Women during pregnancy or breast-feeding 3. Severe mental disease 4. Continuous systemic steroid therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tumor response
- Secondary Outcome Measures
Name Time Method Progression-free and overall survival